Journal of Obstetrics, Gynecology and Cancer Research

Published by: Kowsar

Recurrence and Fertility Rate in Females with Borderline Ovarian Tumor

Azamsadat Mousavi 1 , * , Mahshid Shooshtari 1 , Setare Nassiri 1 , Abas Ali Aipour 1 , Setare Akhavan 1 and Narges Zamani 1
Authors Information
1 Department Gynecology Oncology, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Journal of Obstetrics, Gynecology and Cancer Research: November 2017, 2 (4); e62177
  • Published Online: November 30, 2017
  • Article Type: Research Article
  • Received: September 24, 2017
  • Accepted: October 30, 2017
  • DOI: 10.5812/jogcr.62177

To Cite: Mousavi A, Shooshtari M, Nassiri S, Aipour A A, Akhavan S, et al. Recurrence and Fertility Rate in Females with Borderline Ovarian Tumor, J Obstet Gynecol Cancer Res. 2017 ;2(4):e62177. doi: 10.5812/jogcr.62177.

Copyright: Copyright © 2017, Journal of Obstetrics, Gynecology and Cancer Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Lenhard MS, Mitterer S, Kumper C, Stieber P, Mayr D, Ditsch N, et al. Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort. Eur J Obstet Gynecol Reprod Biol. 2009;145(2):189-94. doi: 10.1016/j.ejogrb.2009.04.031. [PubMed: 19477060].
  • 2. Trillsch F, Mahner S, Ruetzel J, Harter P, Ewald-Riegler N, Jaenicke F, et al. Clinical management of borderline ovarian tumors. Expert Rev Anticancer Ther. 2010;10(7):1115-24. doi: 10.1586/era.10.90. [PubMed: 20645700].
  • 3. Jones MB. Borderline ovarian tumors: current concepts for prognostic factors and clinical management. Clin Obstet Gynecol. 2006;49(3):517-25. [PubMed: 16885658].
  • 4. Lalwani N, Shanbhogue AK, Vikram R, Nagar A, Jagirdar J, Prasad SR. Current update on borderline ovarian neoplasms. AJR Am J Roentgenol. 2010;194(2):330-6. doi: 10.2214/AJR.09.3936. [PubMed: 20093592].
  • 5. Fortin A, Morice P, Thoury A, Camatte S, Dhainaut C, Madelenat P. Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study. Fertil Steril. 2007;87(3):591-6. doi: 10.1016/j.fertnstert.2006.07.1503. [PubMed: 17113086].
  • 6. May T, Virtanen C, Sharma M, Milea A, Begley H, Rosen B, et al. Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary. Gynecol Oncol. 2010;117(1):9-17. doi: 10.1016/j.ygyno.2010.01.006. [PubMed: 20117829].
  • 7. Trope CG, Kaern J, Davidson B. Borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol. 2012;26(3):325-36. doi: 10.1016/j.bpobgyn.2011.12.006. [PubMed: 22321906].
  • 8. Morris RT, Gershenson DM, Silva EG, Follen M, Morris M, Wharton JT. Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol. 2000;95(4):541-7. [PubMed: 10725486].
  • 9. Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, et al. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Gynecol Oncol. 2001;83(3):575-85. doi: 10.1006/gyno.2001.6451. [PubMed: 11733975].
  • 10. Huusom LD, Frederiksen K, Hogdall EV, Glud E, Christensen L, Hogdall CK, et al. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study. Cancer Causes Control. 2006;17(6):821-9. doi: 10.1007/s10552-006-0022-x. [PubMed: 16783610].
  • 11. Du Bois A, Rochon J, Lamparter C, Pfisterer J, A. G. O. Organkommission OVAR PFisterer . Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer. Int J Gynecol Cancer. 2005;15(2):183-91. doi: 10.1111/j.1525-1438.2005.15202.x. [PubMed: 15823098].
  • 12. Morice P. Borderline tumours of the ovary and fertility. Eur J Cancer. 2006;42(2):149-58. doi: 10.1016/j.ejca.2005.07.029. [PubMed: 16326097].
  • 13. Romagnolo C, Gadducci A, Sartori E, Zola P, Maggino T. Management of borderline ovarian tumors: results of an Italian multicenter study. Gynecol Oncol. 2006;101(2):255-60. doi: 10.1016/j.ygyno.2005.10.014. [PubMed: 16307793].
  • 14. Faluyi O, Mackean M, Gourley C, Bryant A, Dickinson HO. Interventions for the treatment of borderline ovarian tumours. Cochrane Database Syst Rev. 2010;(9):7696. doi: 10.1002/14651858.CD007696.pub2. [PubMed: 20824864].
  • 15. Chen RF, Li J, Zhu TT, Yu HL, Lu X. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience. J Ovarian Res. 2016;9:16. doi: 10.1186/s13048-016-0226-y. [PubMed: 26988551].
  • 16. Uzan C, Kane A, Rey A, Gouy S, Duvillard P, Morice P. Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary. Ann Oncol. 2010;21(1):55-60. doi: 10.1093/annonc/mdp267. [PubMed: 19608617].
  • 17. Morice P, Uzan C, Fauvet R, Gouy S, Duvillard P, Darai E. Borderline ovarian tumour, pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. Lancet Oncol. 2012;13(3):103-15. doi: 10.1016/S1470-2045(11)70288-1. [PubMed: 22381933].
  • 18. Seong SJ, Kim DH, Kim MK, Song T. Controversies in borderline ovarian tumors. J Gynecol Oncol. 2015;26(4):343-9. doi: 10.3802/jgo.2015.26.4.343. [PubMed: 26404125].
  • 19. Shih KK, Zhou Q, Huh J, Morgan JC, Iasonos A, Aghajanian C, et al. Risk factors for recurrence of ovarian borderline tumors. Gynecol Oncol. 2011;120(3):480-4. doi: 10.1016/j.ygyno.2010.11.016. [PubMed: 21146201].
  • 20. Koskas M, Uzan C, Gouy S, Pautier P, Lhomme C, Haie Meder C, et al. Fertility determinants after conservative surgery for mucinous borderline tumours of the ovary, (excluding peritoneal pseudomyxoma). Hum Reprod. 2011;26(4):808-14. doi: 10.1093/humrep/deq399. [PubMed: 21262776].
  • 21. Lian C, Chen X, Ni Y, Huang X, Lin Y. Pregnancy after fertility-sparing surgery for borderline ovarian tumors. Int J Gynaecol Obstet. 2016;134(3):282-5. doi: 10.1016/j.ijgo.2016.03.018. [PubMed: 27352738].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader